Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910602 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Arianna Sala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of …. Hauptthemen laut MEDLINE: Antiviral Agents, Herpesvirus 1, Human, Herpesvirus 2, Human, Acyclovir. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, University of Parma.
Abstract (Originalsprache)
Antimicrobial peptides represent a promising alternative to traditional drugs in relation to cost, toxicity, and, primarily, the growing problem of drug resistance. Here, we report on the activity against HSV-1 and HSV-2 of a previously described wide-spectrum synthetic decapeptide, Killer Peptide (KP). As determined by plaque reduction assays, treatment with KP at 100 μg/mL resulted in a reduction in the viral yield titer of 3.5 Logs for HSV-1 and 4.1 Logs for HSV-2. Further evaluation of KP antiviral activity focused on the early stages of the virus replicative cycle, including the determination of the residual infectivity of viral suspensions treated with KP. A direct effect of the peptide on viral particles impairing virus absorption and penetration was shown. The toxicity profile proved to be extremely good, with a selectivity index of 29.6 for HSV-1 and 156 for HSV-2. KP was also active against acyclovir (ACV)-resistant HSV isolates, while HSV subcultures in the presence of sub-inhibitory doses of KP did not lead to the emergence of resistant strains. Finally, the antiviral action of KP proved to be synergistic with that of ACV. Overall, these results demonstrate that KP could represent an interesting addition/alternative to acyclovir for antiviral treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy.
- Clinical and Experimental Medicine Ph.D. Program, University of Modena and Reggio Emilia, 41121 Modena, Italy.
- Laboratory of Microbiology and Virology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
- Microbiome Research Hub, University of Parma, 43124 Parma, Italy.
ORCID-Profile: Francesco Ricchi, Laura Giovati, Stefania Conti, Tecla Ciociola, Claudio Cermelli
Förderung
- Ministero dell'Università e della Ricerca
- University of Parma
Zitieren
APA
Sala, A., Ricchi, F., Giovati, L., Conti, S., Ciociola, T., & Cermelli, C. (2024). Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910602
Vancouver
Sala A, Ricchi F, Giovati L, Conti S, Ciociola T, Cermelli C. Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910602
BibTeX
@article{Sala2024,
author = {Sala, Arianna and Ricchi, Francesco and Giovati, Laura and Conti, Stefania and Ciociola, Tecla and Cermelli, Claudio},
title = {Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910602}
}
EUVIMED